Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD4954. The study includes healthy adults with or without ele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• AZD4954

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Participants, Dyslipidemia | Phase 1 | Status: RECRUITING